NSETrading Window28 Sept 2026 · 28 Sept 2026, 05:55 pm
Trading Window
Indegene Limited · INDGN
✦ AI SummaryResults
Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the finalization and approval of financial results for the quarter and half year ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Indegene Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
INDEGENE_28092026175500_tofiletwclosure_30092026.pdf
View document text
INDGN/SE/2026-27/54
September 28, 2026
BSE Limited, National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block G, Bandra
Dalal Street, Kurla Complex, Bandra (E), Mumbai –
Mumbai- 400001, India. 400 051, India.
Trading symbol: INDGN
Scrip Code: 544172
Dear Sir / Madam,
Subject: Intimation of Closure of Trading Window of the Company for the quarter and half year ended
September 30, 2026
This is to inform that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading)
Regulations, 2015 and the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading
by Insiders, the Trading Window for dealing in the securities of the Company will remain closed with effect
from Thursday, October 01, 2026.
The closure is in connection with the finalization and approval of financial results (standalone and
consolidated) for the quarter and half year ended September 30, 2026.
The trading window shall be re-opened 48 (Forty-Eight) hours after the said results of the Company are
declared and disseminated to the Stock Exchanges.
Accordingly, all the Designated Persons, their immediate relatives and other Insiders of the Company are
advised not to deal in the Equity Shares of the Company during the aforesaid period.
This will also be posted on the company’s website at: https://www.indegene.com/
We request you to kindly take the same on record.
For Indegene Limited
Srishti Ramesh Kaushik
Company Secretary and Compliance Officer
M. No. A21609
Indegene Limited
Third Floor, Aspen G-4 Block, Manyata Embassy
Business Park (SEZ), Outer Ring Road, Nagawara, Bengaluru-
560 045, Karnataka, India
Phone: +91 80 4674 4567, +91 80 4644 7777
compliance.officer@indegene.com
www.indegene.com
CIN: L73100KA1998PLC102040